Concepedia

Martha W. den Hollander

MW

Statistics

Publications

5

Citations

226

H-Index

5

Active since

2014

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Erasmus MC Cancer Institute

Radboud University Medical Center

Radboud University Nijmegen

Martha W. den Hollander is an author at University Medical Center Groningen specializing in medicine, pathology, and ovarian cancer.

Top concepts

Publications per year

2014–2019

5

Publications

5

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET

Martha W. den Hollander, Frederike Bensch, Andor W.J.M. Glaudemans et al. · Journal of Nuclear Medicine · 2015 · 98 citations · Full text

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher et al. · Gynecologic Oncology · 2019 · 74 citations · Full text

, , +7

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study

Cyrillo G. Brahm, Martha W. den Hollander, Roelien H. Enting et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 32 citations · Full text

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer

Diane A.J. van der Biessen, Jourik A. Gietema, Maja J.A. de Jonge et al. · Investigational New Drugs · 2018 · 12 citations · Full text

A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies

Corina N.A.M. Oldenhuis, Walter J. Loos, Brooke Esteves et al. · Clinical Colorectal Cancer · 2014 · 10 citations

, , +7

Rows per page

1–5 of 5